[ad_1] From left to right: Professor of Medicine and Endocrinology at the Faculty of Medicine and Biomedical Sciences of the University of Yaoundé in Cameroon, Jean Claude Mbanya; Professor of Diabetes Metabolism, …
Read More »
[ad_1] October 05, 2018 Belviq, a serotonin 2C receptor agonist, is approved for chronic weight management. According to new data from the CAMELLIA-TIMI 61 study, treatment with lorcaserine (Belviq; Eisai) was associated …
Read More »
[ad_1] "At Takeda, we aim to improve the lives of patients with gastrointestinal illness through the provision of innovative medicines that target the underlying causes of the disease." Our continued dedication to …
Read More »